Skip to content
Business
Prognosis

New Zealand Provisionally Approves Pfizer Vaccine for Ages 5-11

A Covid-19 Vaccination Centre at a pharmacy in Wellington, New Zealand, on Dec. 14.

A Covid-19 Vaccination Centre at a pharmacy in Wellington, New Zealand, on Dec. 14.

Photographer: Birgit Krippner/Bloomberg

New Zealand’s medicines regulator has provisionally approved the use of the Pfizer Covid-19 vaccine for children aged five to 11.

The provisional approval is for two doses of the pediatric vaccine given at least 21 days apart, Medsafe said in a statement Thursday in Wellington. It is an adapted version of the vaccine used for people aged 12 and older, it said.